Skip to main content
Clinical Trials/NL-OMON50075
NL-OMON50075
Recruiting
Not Applicable

Study of the neuromuscular and multisystem features of patients with malignant hyperthermia or rhabdomyolysis related to a RYR1 variant - Multisystem features of malignant hyperthermia and rhabdomyolysis

Radboud Universitair Medisch Centrum0 sites60 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Radboud Universitair Medisch Centrum
Enrollment
60
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \* A history of malignant hyperthermia susceptibility (MHS), confirmed by
  • diagnostic RYR1 variant or IVCT related to a RYR1 variant and/or a history of
  • rhabdomyolysis related to a variant in RYR1
  • \* Minimum age 18 years old.

Exclusion Criteria

  • \* Patients diagnosed with a neuromuscular disease resulting in muscle weakness
  • (apart from RYR1 related rhabdomyolysis and malignant hyperthermia).
  • \* Patients with symptoms of angina pectoris.
  • \* Patients with contra\-indications for MRI\-scan are excluded.
  • Contra\-indications for MRI\-scan include metallic implants (vascular clips,
  • foreign bodies like metallic splinters in the eye, coronary and peripheral
  • artery stents, prosthetic heart valves, pacemakers and ICD\*s, cochlear
  • implants, breast tissue expanders and some other electronic implants or devices
  • and known claustrophobia.
  • \* Current malignancy

Outcomes

Primary Outcomes

Not specified

Similar Trials